 ATLANTA, Aug. 10, 2022 GLOBE NEWSWIRE -- Alimera Sciences, Inc. Nasdaq: ALIM Alimera, a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer, announced today that Rick Eiswirth, Alimeras President and Chief Executive Officer, will deliver a corporate presentation at the HC Wainwright 2nd Annual Ophthalmology Conference being held virtually on Wednesday, August 17, 2022. 